FDA Approves Verdeso Foam of Connetics (PharmaBiz)
Connetics Corporation, a specialty pharmaceutical company that develops and commercializes dermatology products, has announced that the US Food and Drug Administration (FDA) has approved Verdeso (desonide) Foam, 0.05 per cent for the treatment of mild-to-moderate atopic dermatitis.

Spinach Scare's Larger Warning (Los Angeles Times)
Tight FDA budgets have cut produce inspection. Compliance with safety rules is voluntary.